What does this source bring?
Bilateral visual impairment and retinal changes have been reported following the use of RLRL; improvement was observed after exposure was discontinued.
The case report is a safety signal, not an indicator of incidence or evidence that all devices have the same risk profile.
CLAIM-RLRL-CASEScope of testing and verification
- The role of the record
- Source of the claim
- Population
- A girl 12 years old with myopia
- N
- 1
- Geography
- China
- Observation (months)
- 5
- Comparator
- No control group
- Result
- Bilateral visual impairment and retinal changes have been reported following the use of RLRL; improvement was observed after exposure was discontinued.
- Safety
- Changes in the outer layers of the retina in OCT and deterioration of acuity.
- Device/structure
- Eyerising (Suzhou Xuanjia Optoelectronics Technology), as described in JAMA.
- Publisher of the publication
- American Medical Association (AMA)
- Financing
- Not determined within the proven range; see the declaration in full text.
- Conflicts of interest
- Not determined within the proven range. The absence of confirmation does not mean the absence of conflict.
- DOI
- 10.1001/jamaophthalmol.2023.1548
- PMID
- 37227712
- What was checked
- PubMed metadata and available clinical description on the JAMA website.
- Date of verification
- 2026-09-09
This is the editorial card of the publication. The description does not replace the full text, supplementary data or instructions for a specific device.